Journal: International Journal of Molecular Sciences

Article Title: Identification of Actionable Gene Variants in Pulmonary Large-Cell Neuroendocrine Carcinoma: A Real-World Analysis of a Polish Cohort

doi: 10.3390/ijms27072939

Figure Lengend Snippet: The graphic representation of TMEM79::NTRK1 fusion, including exonic (TMEM79 NM_032323.3 exon 3; NTRK1 NM_002529.3 exon 2) and chromosomal (chr1:156256264, chr1:156834146) breakpoint positions based on the output data from the Archer Analysis software version 7.2 (ArcherDX, Inc., Boulder, CO, USA; ( A )) and on the variant visualization by the Alamut Visual Plus v1.12 software (SOPHiA GENETICS, Inc., Boston, MA, USA; ( B )).

Article Snippet: Gene fusion variants were further evaluated using Alamut Visual Plus (v1.12; SOPHiA GENETICS, Inc., Boston, MA, USA).

Techniques: Software, Variant Assay

Journal: Molecular Genetics & Genomic Medicine

Article Title: Genetic testing and employer‐sponsored wellness programs: An overview of current vendors, products, and practices

doi: 10.1002/mgg3.1414

Figure Lengend Snippet: Content Analysis Codebook displays the content analysis codebook that identifies and defines the variables used to collect data on each vendor

Article Snippet: Pathway Genomics , https://www.pathway.com/corporate‐wellness/ , 2009 , San Diego, CA, USA , Traits & Conditions Nutrigenetics Fitness Pharmacogenomics , 14.

Techniques: Sequencing

Journal: Molecular Genetics & Genomic Medicine

Article Title: Genetic testing and employer‐sponsored wellness programs: An overview of current vendors, products, and practices

doi: 10.1002/mgg3.1414

Figure Lengend Snippet: Variability in the type of genetic tests offered by vendors who also offer B2B corporate wellness programs illustrates the percentage of each type of genetic test across the vendors identified within the BTB corporate wellness market. A total of 71 genetic tests for all 15 vendors were identified. There are six insight categories: Nutrigenetics, fitness, traits & conditions, Pharmacogenomics, ancestry & familial, and pathogenic variants were determined. The values (n = x) within each bar represent the number of genetic testing products identified for each insight category. The percent of total row below the bar graph is calculated from n = x/the total number of tests identified in the market (n = 71) × 100.

Article Snippet: Pathway Genomics , https://www.pathway.com/corporate‐wellness/ , 2009 , San Diego, CA, USA , Traits & Conditions Nutrigenetics Fitness Pharmacogenomics , 14.

Techniques:

Journal: Molecular Genetics & Genomic Medicine

Article Title: Genetic testing and employer‐sponsored wellness programs: An overview of current vendors, products, and practices

doi: 10.1002/mgg3.1414

Figure Lengend Snippet: Posttesting health and genetic consultations among vendors of B2B corporate wellness programs and their health‐related genetic testing products. (A) displays the relative percentage of all vendors that provide consultations with their genetic tests. The percentage of vendors providing professional health or genetic testing consultation was calculated from the total count of “Y” (n = 8)/total number of vendors identified (n = 15) × 100. (B) pie chart shows the percentage of all health‐related genetic testing products (n = 62) offered by BTB corporate wellness vendors that contained posttesting health or genetic consultation with a learned professional as a part of the product. The “pharmacogenomics consult” category represents the percentage of products that offered a consult with a health professional to discuss drug sensitivities and medication changes, and the “no consultation” category represents the number of products that did not mention any consultation with a health or genetic professional. The percentage values accompanying each category is calculated from the total number of tests for each category/the total number of health‐related genetic tests identified (62) *100. Data for each category of consultation were gathered independently.

Article Snippet: Pathway Genomics , https://www.pathway.com/corporate‐wellness/ , 2009 , San Diego, CA, USA , Traits & Conditions Nutrigenetics Fitness Pharmacogenomics , 14.

Techniques:

Journal: Molecular Genetics & Genomic Medicine

Article Title: Genetic testing and employer‐sponsored wellness programs: An overview of current vendors, products, and practices

doi: 10.1002/mgg3.1414

Figure Lengend Snippet: Variability in posttesting health and genetic consultations offered by type of genetic test. The percentage of insights providing consultations with a learned professional was calculated independently for each insight. For example, if a single genetic test provides both Fitness and Nutrigenetics insight and offers a genetic or health consult a percentage point is added to both the Fitness and Nutrigenetics insights in the row titled “percent with genetic or health consultations.” N = x is total number of tests in each category. Each category was coded independently.

Article Snippet: Pathway Genomics , https://www.pathway.com/corporate‐wellness/ , 2009 , San Diego, CA, USA , Traits & Conditions Nutrigenetics Fitness Pharmacogenomics , 14.

Techniques:

Journal: Breast Cancer (Tokyo, Japan)

Article Title: Pharmacogenomic–pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer

doi: 10.1007/s12282-019-00952-9

Figure Lengend Snippet: Associations between the total activity of TAM or TOR and gene polymorphisms

Article Snippet: Pharmacogenomics (PGx) analysis for CYP2D6, CYP2C19 , and ABCC2 (MRP2) was conducted by FALCO Biosystems (Kyoto, Japan).

Techniques: Activity Assay

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Article Title: Prescription medication changes following direct-to-consumer personal genomic testing: Findings from the Impact of Personal Genomics (PGen) Study

doi: 10.1038/gim.2016.141

Figure Lengend Snippet: Baseline characteristics of PGen Study Participants (n = 961)

Article Snippet: A further 42 participants (all from 23andMe) were excluded because their pharmacogenomic results were not available to researchers.

Techniques: Standard Deviation

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Article Title: Prescription medication changes following direct-to-consumer personal genomic testing: Findings from the Impact of Personal Genomics (PGen) Study

doi: 10.1038/gim.2016.141

Figure Lengend Snippet: Pharmacogenomic results in the PGen Study, stratified by personal genomic testing company (n = 961)

Article Snippet: A further 42 participants (all from 23andMe) were excluded because their pharmacogenomic results were not available to researchers.

Techniques:

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Article Title: Prescription medication changes following direct-to-consumer personal genomic testing: Findings from the Impact of Personal Genomics (PGen) Study

doi: 10.1038/gim.2016.141

Figure Lengend Snippet: Logistic regression of specific medication changes reported post-PGT on number of atypical response pharmacogenomic results received (n = 961)

Article Snippet: A further 42 participants (all from 23andMe) were excluded because their pharmacogenomic results were not available to researchers.

Techniques: